TriSalus Life Sciences (TLSI) Balance Sheet: Assets & Liabilities

TriSalus Life Sciences (TLSI) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), TriSalus Life Sciences reported total assets of $35.33M and total liabilities of $69.19M. Shareholders' equity was negative at −$33.86M, meaning liabilities exceed assets. Total debt stood at $33.21M against $20.44M in cash and short-term investments, a net debt position of $12.77M.

TriSalus Life Sciences Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for TriSalus Life Sciences, Inc. (TLSI) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2021	FY 2020
Period ending	Dec 2025	Dec 2024	Mar 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	20.44	8.53	11.78	11.78	9.41	30.30	4.49
Cash & Short-Term Investments	20.44	8.53	11.78	11.78	9.41	30.30	4.49
Accounts Receivable	6.56	5.09	3.55	3.55	1.56	1.36	0.62
Inventory	3.08	4.05	2.55	2.55	1.47	1.29	0.57
Other Current Assets	2.17	3.01	2.99	2.99	4.77	2.18	0.41
Total Current Assets	32.24	20.67	20.86	20.86	17.21	35.13	6.08
Non-Current Assets
Property, Plant & Equipment (Net)	2.67	2.88	3.27	3.27	3.61	1.80	1.26
Long-Term Investments	0.40	0.35	0.00	-	0.25	0.00	0.00
Intangible Assets	0.00	0.00	0.00	-	0.80	0.79	0.74
Other Non-Current Assets	0.42	0.42	0.47	0.47	0.37	0.12	0.05
Total Non-Current Assets	3.09	3.30	3.74	3.74	4.78	2.71	2.05
Total Assets	35.33	23.97	24.60	24.60	22.00	37.84	8.13
Current Liabilities
Accounts Payable	3.00	2.27	3.39	3.39	4.95	1.30	0.61
Short-Term Debt	0.17	0.22	0.35	-	0.37	0.00	42.18
Current Portion of Long-Term Debt	-	-	-	-	-	-	42.18
Accrued Liabilities	5.68	4.87	-	10.56	3.15	3.14	6.73
Other Current Liabilities	0.23	0.38	10.95	0.39	20.66	5.07	11.95
Total Current Liabilities	11.50	10.23	14.69	14.69	32.36	6.37	54.75
Non-Current Liabilities
Long-Term Debt	33.05	22.08	1.24	1.24	1.59	0.00	0.00
Other Non-Current Liabilities	23.42	16.22	35.73	35.73	0.37	0.56	3.54
Total Non-Current Liabilities	57.69	39.64	36.98	36.98	165.97	0.56	3.54
Total Liabilities	69.19	49.87	51.66	51.66	198.33	6.93	58.29
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00	0.01	0.01
Retained Earnings	-330.58	-279.55	-249.50	-249.50	-186.36	-136.34	-107.50
Additional Paid-in Capital	296.72	253.65	222.44	222.44	10.03	6.73	1.36
Shares Outstanding	50.00	31.28	-	26.41	26.32	26.32	-
Total Stockholders' Equity	-33.86	-25.89	-27.07	-27.07	-176.33	30.90	-50.16
Total Liabilities & Equity	35.33	23.97	24.60	24.60	22.00	37.84	8.13

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About TriSalus Life Sciences Balance Sheet

How much debt does TriSalus Life Sciences have?

TriSalus Life Sciences had total debt of $33.21M as of Dec 31, 2025, against $20.44M in cash and short-term investments. Total debt was $22.30M a year earlier.

What are TriSalus Life Sciences's total assets?

TriSalus Life Sciences reported total assets of $35.33M as of Dec 31, 2025, up 47.4% from $23.97M a year earlier. Total liabilities were $69.19M.

What is TriSalus Life Sciences's shareholders' equity?

TriSalus Life Sciences's shareholders' equity was negative at −$33.86M as of Dec 31, 2025, so its liabilities exceeded its assets.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition